Press "Enter" to skip to content

Sanofi To Manufacture 125 Million COVID-19 Vaccine Doses For Rival Pfizer-BioNTech

  • French drug maker Sanofi SA (NASDAQ: SNY) will manufacture 125 million doses of the COVID-19 vaccine co-developed by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) in its Frankfurt plant starting this summer.
  • As Sanofi’s COVID-19 vaccine faces delays, the French government has been pressing …

Full story available on Benzinga.com

This post was originally published on this site

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *